Fortress Biotech, Inc. - Common Stock - fluxo de caixa (NASDAQ:FBIO)

Financials

Visão geral Relatórios Estatísticas Dividendos

Fluxo de caixa operacional -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M Fluxo de caixa de investimento -7.16 M40.51 M-22.93 M-2.1 M-15 M10.12 M 8.96 M Fluxo de caixa de financiamento 172.41 M148.99 M75.32 M32.74 M70.64 M77.44 M -2.09 M Fluxo de caixa livre -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M

Fortress Biotech, Inc. - Common Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

FBIO

Financials

Fortress Biotech, Inc. - Common Stock

Notícias

Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)

Transcrição de resultados: Journey Medical registra alta de 21% na receita no 1º tri de 2026

Avenue Therapeutics licenses ATX-04 for Pompe disease treatment

Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

FDA aprova primeiro tratamento para doença de Menkes em crianças

FDA approves first treatment for Menkes disease in children

FDA define nova data PDUFA para terapia da Fortress Biotech contra doença de Menkes

FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy

Fortress Biotech anuncia reenvio de NDA para tratamento da doença de Menkes